Success Metrics

Clinical Success Rate
88.9%

Based on 8 completed trials

Completion Rate
89%(8/9)
Active Trials
1(5%)
Results Posted
0%(0 trials)
Terminated
1(5%)

Phase Distribution

Ph not_applicable
16
73%
Ph phase_3
1
5%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution17 total trials
Phase 3Large-scale testing
1(5.9%)
N/ANon-phased studies
16(94.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

88.9%

8 of 9 finished

Non-Completion Rate

11.1%

1 ended early

Currently Active

1

trials recruiting

Total Trials

22

all time

Status Distribution
Active(2)
Completed(8)
Terminated(1)
Other(11)

Detailed Status

unknown11
Completed8
Active, not recruiting1
Enrolling by invitation1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
22
Active
1
Success Rate
88.9%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (5.9%)
N/A16 (94.1%)

Trials by Status

completed836%
active_not_recruiting15%
enrolling_by_invitation15%
unknown1150%
terminated15%

Recent Activity

Clinical Trials (22)

Showing 20 of 22 trialsScroll for more
NCT07567664Not Applicable

Tracking and Predicting How Brain Damage Spreads in Neurodegenerative Diseases

Enrolling By Invitation
NCT03455582Not Applicable

Cognition Evolution and MRI Markers in PPMS Patients on 2 Years

Active Not Recruiting
NCT03862222

Atlas of Retinal Imaging in Alzheimer's Study

Completed
NCT04769011Not Applicable

Motor Impairments in Children With Autism Spectrum Disorder: a Multimodal Approach

Completed
NCT03406741Not Applicable

Neuropsychological Development and Functional Outcome Sin Children With Hirschsprung Disease at School Age

Completed
NCT02811653Not Applicable

Motor Slowing and Its Lesion-related Correlates in Alzheimer's Disease

Unknown
NCT03692975Not Applicable

MRI Hippocampal Microstructure and Episodic Memory in Early Multiple Sclerosis

Completed
NCT03768648Not Applicable

Cognition and MRI Markers in MS Patients With Aubagio® Treatment

Completed
NCT05735405Not Applicable

Aerobic Exercise and Cognitive Training in Patients With Stroke

Unknown
NCT05640141

Pre-demential Motoric Cognitive Risk Syndrome in Ageing Subjects

Unknown
NCT05569083

PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With Machine Learning

Unknown
NCT02554331Not Applicable

Gait and REM Sleep Behavior Disorder

Terminated
NCT03923569Not Applicable

Epileptiform Activity During REM Sleep in Alzheimer's Disease

Unknown
NCT03998852Phase 3

In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.

Unknown
NCT03518710Not Applicable

Vision, Attention and Reading in Neurofibromatosis Type 1 (NF1) Children

Unknown
NCT02901002

Body Perception and Complex Regional Pain Syndrome

Completed
NCT00914030

Visual Exploration and Attention: Studies in Patients With Schizophrenia and Autism Spectrum Disorders

Unknown
NCT02805088Not Applicable

Emotions in Schizophrenia and Bipolar Disorders: a Common Vulnerability?

Unknown
NCT02438124Not Applicable

Rhythmic Auditory Stimulation Optimalization for Gait Improvement in Parkinson's Disease - BeatPark Study

Unknown
NCT01741662Not Applicable

Prevalence of Psychocognitive Impairments in Adolescents Surviving Childhood Leukemia : LEA-PsyCog

Unknown

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
22